Robert Embree and Jason Allchin Team Up to Start EmeritusDX Share Article Our common purpose is to save lives, one specimen at a time. COSTA MESA, Calif. (PRWEB) January 20, 2021 Today Robert Embree and Jason Allchin announced they would be forming EmeritusDX, a cancer diagnostics company located in Southern California. With a focus on oncology, their Anatomic Pathology and FISH laboratories will provide diagnostic services as well as research testing for the development of nextgen tests and therapies. Mr. Embree is an experienced executive with over 30 years of leadership within the healthcare and laboratory industry. He has held numerous executive roles and was most recently co-founder and Executive Vice President of Operations at Pathnostics. “Our common purpose is to save lives one specimen at a time. We accomplish this by solving the medical, scientific, and logistical dilemmas that impede delivering the best patient care.”